Rethinking Detox: Beyond Fads to Foundational Liver Support Webinar

This webinar focuses on liver health and detoxification, covering:

1. How the phase 1 and phase 2 detoxification pathways work, with phase 3 elimination for context
2. What can interfere with detoxification
3. Key signs and symptoms to look for in clients
4. How to support detoxification from a naturopathic and functional perspective

Hosted by Ella Kaur (Practitioner Lead, Registered Nutritionist and Nutritional Therapy Practitioner) with Richa Puri, this webinar provides a pharmacist's perspective on medications and detoxification burden.

Key Points Discussed

Detoxification pathways (phase 1 and phase 2 focus)

• Phase 1 (largely cytochrome P450 enzymes) modifies toxins through oxidation, reduction and hydrolysis. This often makes them more reactive so they can be conjugated in phase 2.
• Phase 2 conjugation binds toxins to make them less toxic and more water-soluble for excretion.

Core nutrients and food foundations

• Phase 1 support includes B vitamins (B2, B6, B12), glutathione and branched-chain amino acids, plus flavonoids and phospholipids from a diverse plant-rich diet.
• Other supports for intermediate metabolites include vitamins A and C, selenium, zinc, copper, manganese, coenzyme Q10, cruciferous vegetables, and milk thistle/silymarin.

Phase 3 elimination considerations

• Bowel regularity (2–3 bowel movements a day).
• Hydration for kidney elimination.
• Constipation management.
• Fibre and probiotics as needed.

Impaired detox consequences

• An imbalance between phase 1 and phase 2 can cause a 'backlog'. This increases toxin levels, with potential downstream effects such as DNA, protein and lipid damage.
• Links are made to oestrogen clearance problems, histamine intolerance, and ammonia accumulation affecting the brain (e.g., brain fog).

Pharmacist insight: medication burden on liver detox

1. Many medications rely on cytochrome P450 pathways.
2. Enzyme inducers may speed up metabolism and create reactive intermediates.
3. Enzyme inhibitors may slow clearance, allowing build-up.
4. Directly hepatotoxic drugs (notably paracetamol, statins and methotrexate) can stress detox capacity, especially through glutathione depletion and other nutrient strain (e.g., methotrexate depleting folic acid).
5. Polypharmacy increases liver demand.

Women's health angle (perimenopause and oestrogen)

• Perimenopause is a time of oestrogen fluctuation, including possible 'unopposed oestrogen', which increases detox workload.
• The gut microbiome and beta-glucuronidase are highlighted as part of oestrogen recirculation dynamics.

Key Takeaways

1. Assessing a client's liver detoxification includes both biochemical and symptom patterns, especially when detox pathways are overloaded or imbalanced.
2. Support should start with diet, gut and lifestyle foundations, then add targeted supplementation gradually (avoid 'speeding up' too fast).
3. Medication burden matters: enzyme inducers/inhibitors and hepatotoxic drugs can increase reactive intermediates or deplete key nutrients needed for conjugation and elimination.

Conclusion

This webinar provides a structured, practitioner-focused framework for understanding liver detoxification phases 1 and 2. It links them to nutrient needs, gut elimination requirements and common clinical symptom clusters. It also brings in a pharmacist's perspective on medication, highlighting that detox support must account for polypharmacy, drug mechanisms, nutrient depletion and women's hormonal transitions.